SCHEMBL10922650

SCHEMBL10922650

Cc1ccc(OCF)c(OCF)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
L3MBTL1 Q9Y468 12/20 0.47
MAPT P10636 10/20 0.47
HPGD P15428 7/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
ALDH1A1 P00352 2/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL4 Q8NA19 1/20 0.44
L3MBTL3 Q96JM7 1/20 0.44
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12433408 0.86 TSHR (0.53) L3MBTL1MAPTHPGDCYP2C9ALDH1A1
SCHEMBL13905218 0.85 MRGPRX4 (0.48) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL10458220 0.85 L3MBTL1 (0.51) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL15211123 0.81 L3MBTL1 (0.38) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL805356 0.81 MAPT (0.61) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL13461855 0.80 MAPT (0.37) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL17207217 0.80 L3MBTL1 (0.52) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL19198866 0.80 L3MBTL4 (0.41) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL17012730 0.79 ACHE (0.48) ACHEL3MBTL1MAPTHPGDCYP2C9
SCHEMBL12433468 0.78 CYP1A2 (0.41) ACHEL3MBTL1MAPTHPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025301-A1 Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases TONGJI UNIVERSITY (CN) 2023-01-26 US disclosed
US-4596880-A Pesticides BAYER AKTIENGESELLSCHAFT (DE) 1986-06-24 US disclosed
US-4438275-A 2,2-DIFLUORO-BENZODIOXOLES BAYER AKTIENGESELLSCHAFT (DE) 1984-03-20 US disclosed
US-4310540-A PYRETHROID-LIKE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1982-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025301-A1 Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases TNNI3, TNNT2, MKI67 ACHE 4394/4885L3MBTL1 4565/4885MAPT 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.